Pfizer Inc (PFE) Lobbying Data
PFE lobbying summary
Pfizer (PFE) has reported $151.5M in federal lobbying spending across 489 Senate LDA filings since 2020. Its most frequent lobbying issues are Health Issues, Trade, Taxation, Medicare/Medicaid. Lobbying firms used include Pfizer Inc., Bgr Government Affairs, Altrius Group, LLC.
Lobbying spending by year
| Year | Reported spend |
|---|---|
| 2026 | $16.3M |
| 2025 | $31.3M |
| 2024 | $26.4M |
| 2023 | $17.7M |
| 2022 | $28.3M |
| 2021 | $16.6M |
See insider trading for PFE or the Lobbying Heavyweights strategy.
Source: Senate Lobbying Disclosure Act (LD-2) filings. The current year is partial.